Emerging Biosimilars in Therapeutics

Emerging Biosimilars in Therapeutics Photo
The investigations in the field of biologics have made another road for the clinicians towards better malady administration. The developing biologics have just showed productive results in treatment of afflictions like those of psoriasis, rheumatic joint pain, certain growths, incendiary inside disease(IBD) and so forth. Emerging Biosimilar insulins are probably going to enter the insulin scene as licenses for major marked insulin items begin to lapse in the following couple of years. The primary topic of this track is to have sound information in the rising biosimilars like Filgrastim, Pegfilgrastim, Recombinant blood items, helpful proteins, antibodies, Biosimilar antibodies, Growth hormones, Biosimilar peptides, restorative proteins and other biosimilar improvements and their effects.
  • Cancer therapeutics
  • Insulin Biosimilars
  • Biosimilars in rheumatology
  • Biosimilar Interleukins
  • Biosimilar monoclonal antibodies
  • Biosimilar Epoetins
  • Biosimilar TNF-Alpha
  • Biosimilars in Fertility Treatment
  • Recombinant blood products
  • Recombinant therapeutic proteins
  • Biosimilar peptides
  • Growth hormones
  • Recombinant vaccines

Are you interested in

Mail us at

Programs & Speaking Engagement
biosimilars@alliedmeetings.com
Sponsorship
john.wilson@alliedmeetings.com
Group Discounts and Delegates
biosimilars@alliedmeetings.com
More details about sponsorship:sponsors@alliedacademies.com

Authorization Policy

By registering for the conference you grant permission to Allied Academies to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute,broadcast,edit and/or digitize the resulting images and materials in publications, advertising materials,or in any other form worldwide without compensation. Taking of photographs and/or video taping during any session is prohibited. Contact us for any queries
Copyright © 2017-2018 Allied Academies, All Rights Reserved.